Influence of Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade
Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0b013e31817fd8f3
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)